Arrow image

00

Days

:

00

Hours

:

00

Mins

:

00

Secs

Visit us at Bio.IT 2025

10 Sep 2024

FDA Rule on Lab Developed Tests (LDTs)

2 | Understanding Compliance Tiers for Laboratory Developed Tests (LDTs)

WRITTEN BY

Divya Anantsri

SHARE THIS

Blog

In our previous blog in this series, we summarized the FDA’s plan to phase out the enforcement discretion policy for LDTs. To recap, the phase-out policy involves five stages spread across five years.

In this blog, we will elaborate on which rules apply to the various types of LDTs.

The types of compliance required are divided into Tiers 0-IV, as shown in the table below.

Tier 0 lists tests for which the compliance required by the final rule is already expected and enforced.

Thus, the stringency of compliance depends on the type of LDTs being manufactured.

If you are a new molecular LDT manufacturer, watch out for our next blog, which will elaborate on the specific processes that need to be set up and, importantly, how Strand can help.

Explore the rest of the blog series below:

Today’s Pick
from Blogs

24 Jan 2025

AI/ML Series

2 | AI/ML in Spatial Transcriptomics and Cell Segmentation

Sakshi Shinghal

Know More

24 Jan 2025

Strand’s Methylation Pipeline Series

2 | Strand’s Methylation Pipeline - An Overview - Part 2

Divya Anantsri

Know More

Your Next
Blog Recommendations

21 Oct 2024

Microbiome Analysis Series

1 | An Ecosystem of Possibilities—Applications of Microbiome Analysis

Sanjna Banerjee

Know More

04 Jul 2024

Overcoming Data Management Hurdles in Multiomics Analysis

Divya Anantsri

Know More

28 Jun 2024

Somatic Variations Series

4 | Somatic Variants: Towards Better Therapy

Sanjna Banerjee

Know More

Let's
Talk

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Form